Rapid report
Ezetimibe for the prevention of cardiovascular Events - Rapid report
Report documents
-
Extract of the rapid report
Ezetimibe for the prevention of cardiovascular Events - Rapid report
-
Rapid Report
Ezetimibe for the prevention of cardiovascular Events - Rapid report
Press releases
Ezetimibe reduces the risk of heart attacks and strokes
Given in addition to statin therapy, ezetimibe has a preventive effect in patients with CHD and acute coronary syndrome
Project details
- Project no.
- A18-83
- Commission
- Commission awarded on 27.11.2018 by the Federal Joint Committee (GBA).
- Report type
- Rapid report
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Digestion, metabolism and hormones
- Note
-
The present version 2.0 of 3 September 2019 replaces version 1.0 of the rapid report of 28 June 2019. There have been changes in the risk of bias for the outcome “serious cardiovascular events”.